Docoh
Loading...

GWPRF GW Pharmaceuticals

APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
27 Jan 22
The present invention relates to the use of cannabidiol (CBD) in the treatment of epilepsy which results from mutation of the KCNT1 gene.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 18 Feb 20
APP
Utility
Cannabidiol-type Cannabinoid Compound
20 Jan 22
The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament.
Geoffrey GUY, Volker KNAPPERTZ, Benjamin WHALLEY, Royston GRAY, Jacqueline CILIA, Amesha PATEL, Hannah STRAKER
Filed: 20 Nov 19
APP
Utility
Use of Cannabinolids In the Treatment of Epilepsy
13 Jan 22
The present invention relates to the use of cannabidiol (CBD) in the treatment of epilepsy which results from mutation of the GRIN2A gene.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 28 Nov 19
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
6 Jan 22
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 16 Sep 21
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
30 Dec 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 10 Sep 21
APP
Utility
Use of Cannabidiol In the Treatment of Epilepsy
28 Oct 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 21 Jul 20
APP
Utility
Combination of Cannabinoids In the Treatment of Leukaemia
7 Oct 21
The present invention relates to the use of a combination of two different cannabinoids in the treatment of leukaemia.
Stephen Wright, Wai Liu, Katherine Scott, Angus Dalgleish
Filed: 15 Apr 21
APP
Utility
Use of Cannabidiol In the Treatment of Epilepsy
23 Sep 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC).
Geoffrey GUY, Stephen Wright, Elizabeth Thiele
Filed: 7 Jun 21
APP
Utility
Methods of Treating Tuberous Sclerosis Complex with Cannabidiol and Everolimus
2 Sep 21
The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Geoffrey GUY, Volker KNAPPERTZ, Eduardo DUNAYEVICH, David CRITCHLEY
Filed: 1 Mar 21
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
12 Aug 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 27 Apr 21
APP
Utility
Pharmaceutical Formulation
22 Jul 21
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray.
Brian Anthony Whittle
Filed: 1 Oct 20
APP
Utility
Use of Cannabidiolic Acid In the Treatment of Autism Spectrum Disorder and Associated Disorders
8 Jul 21
The present invention relates to the use of cannabidiolic acid (CBDA) in the treatment of autism spectrum disorder (ASD) and ASD-associated disorders, such as Fragile X syndrome (FXS); Rett syndrome (RS); or Angelman syndrome (AS).
Geoffrey GUY, Stephen WRIGHT, James BRODIE, Marie WOOLLEY-ROBERTS, Rafael MALDONADO, Daniela PAROLARO, Livio LUONGO
Filed: 21 Dec 20
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
1 Jul 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 11 Mar 21
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
17 Jun 21
The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy who are concurrently taking immunosuppressant drugs.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 30 Nov 18
APP
Utility
Use of Cannabinoids In the Treatment of Seizures As Associated with Lennox-gastaut Syndrome
10 Jun 21
The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with Lennox-Gastaut syndrome (LGS) who are deemed to be treatment failures on their existing medication.
Geoffrey GUY, Volker KNAPPERTZ
Filed: 15 Nov 18
APP
Utility
Use of Cannabidiol In the Treatment of Epilepsy
20 May 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC).
Geoffrey GUY, Stephen WRIGHT, Elizabeth THIELE
Filed: 12 Jan 21
APP
Utility
Extraction of Pharmaceutically Active Components from Plant Materials
6 May 21
The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (BDS) for incorporation in to a medicament.
BRIAN ANTHONY WHITTLE, Colin A. Hill, Ian R. Flockhart, David Victor Downs, Peter Gibson, Gary William Wheatley
Filed: 18 Jun 20
APP
Utility
Use of the Phytocannabinoid Cannabidivarin (CBDV) In the Treatment of Epilepsy
8 Apr 21
This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy.
Ben WHALLEY, Claire WILLIAMS, Gary STEPHENS, Takashi FUTAMURA
Filed: 4 Sep 20
APP
Utility
Use of Cannabinoids In the Treatment of Epilepsy
1 Apr 21
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen Wright, Orrin Devinsky
Filed: 11 Dec 20
APP
Utility
Use of Cannabinoids In the Treatment of a Neurodegenerative Disease or Disorder
18 Mar 21
The present invention relates to the use of cannabinoids in the treatment of a neurodegenerative disease or disorder.
Benjamin Whalley, William Hind, Royston Gray, Javier Fernandez-Ruiz, Eva De Lago, Carmen Rodriguez-Cueto, Laura Garcia-Toscano, Irene Santos-Garcia
Filed: 10 Jul 18
Patents are sorted by USPTO publication date, most recent first